Product Information
DIOVAN HCT 160-12.5 MG TAB is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $11.4803 per EA under NDC 00078031534. Its NADAC has been published 480 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the valsartan and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5; 160 mg/1; mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078031534
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
New Drug (NDA)
FDA Application
NDA020818On Market Since
3/6/1998
Pharmacological Classes
Price Statistics
The NADAC for DIOVAN HCT 160-12.5 MG TAB has been published 480 times since Nov 28, 2013, and over the history we have for it it has risen 170.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4803 per EA |
|---|---|
| All-time high | $11.5353 (Jun 10, 2026) |
| All-time low | $4.2376 (Nov 28, 2013) |
| 52-week high | $11.5353 |
| 52-week low | $11.0914 |
| Median price | $8.6120 |
| Average price | $8.2822 |
| Largest weekly change | +18.1% (Jun 19, 2024) |
| Weeks tracked | 480 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DIOVAN HCT 160-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DIOVAN HCT 160-12.5 MG TAB, manufactured by Novartis Pharmaceuticals Corporation, is $11.4803 per EA (NDC 00078031534), effective Jun 24, 2026.
How has the price of DIOVAN HCT 160-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for DIOVAN HCT 160-12.5 MG TAB has risen 170.9%. It has been tracked across 480 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIOVAN HCT 160-12.5 MG TAB?
Since Nov 28, 2013, the NADAC for DIOVAN HCT 160-12.5 MG TAB has ranged from a low of $4.2376 (Nov 28, 2013) to a high of $11.5353 (Jun 10, 2026), with a median of $8.6120 per EA.
Are there cheaper alternatives to DIOVAN HCT 160-12.5 MG TAB?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB, is $0.1136 per EA — about 99% below DIOVAN HCT 160-12.5 MG TAB.
Who manufactures DIOVAN HCT 160-12.5 MG TAB?
DIOVAN HCT 160-12.5 MG TAB (NDC 00078031534) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification